Results
|
1221.
|
GABAA receptors containing ρ1 subunits contribute to in vivo effects of ethanol in mice. [electronic resource] by
- Blednov, Yuri A
- Benavidez, Jillian M
- Black, Mendy
- Leiter, Courtney R
- Osterndorff-Kahanek, Elizabeth
- Johnson, David
- Borghese, Cecilia M
- Hanrahan, Jane R
- Johnston, Graham A R
- Chebib, Mary
- Harris, R Adron
Producer: 20140916
In:
PloS one vol. 9
Availability: No items available.
|
|
1222.
|
|
|
1223.
|
Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease. [electronic resource] by
- Berggren, Kiersten L
- Chen, Jianfang
- Fox, Julia
- Miller, Jonathan
- Dodds, Lindsay
- Dugas, Bryan
- Vargas, Liset
- Lothian, Amber
- McAllum, Erin
- Volitakis, Irene
- Roberts, Blaine
- Bush, Ashley I
- Fox, Jonathan H
Producer: 20160609
In:
Redox biology vol. 4
Availability: No items available.
|
|
1224.
|
|
|
1225.
|
|
|
1226.
|
|
|
1227.
|
|
|
1228.
|
Systemic administration of donepezil attenuates the efficacy of environmental enrichment on neurobehavioral outcome after experimental traumatic brain injury. [electronic resource] by
- Bondi, Corina O
- Yelleswarapu, Narayana K
- Day-Cooney, Julian
- Memarzadeh, Kimiya
- Folweiler, Kaitlin A
- Bou-Abboud, Carine E
- Leary, Jacob B
- Cheng, Jeffrey P
- Tehranian-DePasquale, Roya
- Kline, Anthony E
Producer: 20181004
In:
Restorative neurology and neuroscience vol. 36
Availability: No items available.
|
|
1229.
|
|
|
1230.
|
|
|
1231.
|
|
|
1232.
|
A gain-of-function mutation in the GABA receptor produces synaptic and behavioral abnormalities in the mouse. [electronic resource] by
- Homanics, G E
- Elsen, F P
- Ying, S-W
- Jenkins, A
- Ferguson, C
- Sloat, B
- Yuditskaya, S
- Goldstein, P A
- Kralic, J E
- Morrow, A L
- Harrison, N L
Producer: 20050429
In:
Genes, brain, and behavior vol. 4
Availability: No items available.
|
|
1233.
|
|
|
1234.
|
|
|
1235.
|
|
|
1236.
|
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models. [electronic resource] by
- Payne, Joseph E
- Bonnefous, Céline
- Symons, Kent T
- Nguyen, Phan M
- Sablad, Marciano
- Rozenkrants, Natasha
- Zhang, Yan
- Wang, Li
- Yazdani, Nahid
- Shiau, Andrew K
- Noble, Stewart A
- Rix, Peter
- Rao, Tadimeti S
- Hassig, Christian A
- Smith, Nicholas D
Producer: 20101228
In:
Journal of medicinal chemistry vol. 53
Availability: No items available.
|
|
1237.
|
|
|
1238.
|
|
|
1239.
|
|
|
1240.
|
|